Moderna says its vaccine gives immunity against new COVID-19 variant

 

• Issuing a statement, Moderna (NASDAQ:MRNA) says it expects that the immunity offered by its COVID-19 vaccine would be protective against the new variants of the SARS-CoV-2 virus recently detected in the U.K. However, the company plans to run tests the confirm the activity of the vaccine against any strain.
• The vaccine expressing the full-length Spike protein of the SARS-COV-2 virus can generate the neutralizing antibody responses to multiple domains of the protein. The full-length Spike protein is 1,273 amino acids long. 
• With recent variants with multiple mutations causing changes to amino acid sequence could represent less than 1% difference from the spike protein encoded by Moderna’s vaccine, the statement added.
• The vaccine had been proven to be effective in tests against a number of previous variants of the SARS-CoV-2 virus that emerged since the first outbreak of the pandemic.
• Amid fears over the new coronavirus strain, thought to be highly transmissible than its predecessors, the shares of COVID-19 vaccine makers witnessed sharp losses yesterday. 
• https://seekingalpha.com/news/3647149-moderna-says-vaccine-gives-immunity-against-new-covidminus-19-variant